View Exam | PowerPak

1. In the aging population, declining organ function does not lengthen the half-life of which opioid?

A. Codeine B. Morphine C. Methadone D. Buprenorphine E. Unsure

2. In the aging population, adding a gabapentinoid to a pain treatment regimen can increase their risk of __________.

A. Respiratory depression and falling B. Agitation and disorientation C. Somnolence and headaches D. Hypotonia and diaphoresis E. Unsure

3. When dementia patients have chronic pain, which of their neuropsychiatric symptoms can be attenuated by adequately treating their chronic pain?

A. Hitting, anxiety, apathy B. Restlessness, pacing, verbal aggression C. Cursing, irritability, making strange noises D. Sleep problems, depression, kicking E. Unsure

4. A recent Cochrane review found that ___ were effective in treating chronic pain in children and adolescents.

A. Antidepressants B. Antiepileptics C. NSAIDs D. None of the above E. Unsure

5. A daily opioid dose higher than ___ MME is considered the threshold for increased risk of harm from opioids in the aging population.

A. 50 B. 70 C. 90 D. 110 E. Unsure

6. Because so many incarcerated people have an active substance use disorder, opioids should _____

A. Never be prescribed to them under any circumstance B. Be prescribed only as part of end-of-life care C. Be prescribed only for post-operative pain D. Be considered if first-line nonopioid therapy fails E. Unsure

7. All people who inject drugs should be screened for _________.

A. HCV and RSV B. HIV and EBV C. HCV and HIV D. HPV and RSV E. Unsure

8. Which validated screening tool for predicting prescription opioid misuse is backed by the strongest evidence for its accuracy?

A. MOBID-2 B. SOAPP-R C. COMM D. MPQ E. Unsure

9. In the incarcerated population, which MOUD is effective for treating SUD and improving mental health symptoms?

A. Naltrexone B. Methadone C. Buprenorphine D. All are effective E. Unsure

10. The CDC's recommendations on prescribing opioids do not include _______.

A. Information about co-prescribing an opioid with a benzodiazepine B. Protocols for children C. Risk mitigation strategies D. Treatment for OUD E. Unsure

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. In the aging population, declining organ function does not lengthen the half-life of which opioid?

2. In the aging population, adding a gabapentinoid to a pain treatment regimen can increase their risk of __________.

3. When dementia patients have chronic pain, which of their neuropsychiatric symptoms can be attenuated by adequately treating their chronic pain?

4. A recent Cochrane review found that ___ were effective in treating chronic pain in children and adolescents.

5. A daily opioid dose higher than ___ MME is considered the threshold for increased risk of harm from opioids in the aging population.

6. Because so many incarcerated people have an active substance use disorder, opioids should _____

7. All people who inject drugs should be screened for _________.

8. Which validated screening tool for predicting prescription opioid misuse is backed by the strongest evidence for its accuracy?

9. In the incarcerated population, which MOUD is effective for treating SUD and improving mental health symptoms?

10. The CDC's recommendations on prescribing opioids do not include _______.

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. In the aging population, declining organ function does not lengthen the half-life of which opioid?

2. In the aging population, adding a gabapentinoid to a pain treatment regimen can increase their risk of __________.

3. When dementia patients have chronic pain, which of their neuropsychiatric symptoms can be attenuated by adequately treating their chronic pain?

4. A recent Cochrane review found that ___ were effective in treating chronic pain in children and adolescents.

5. A daily opioid dose higher than ___ MME is considered the threshold for increased risk of harm from opioids in the aging population.

6. Because so many incarcerated people have an active substance use disorder, opioids should _____

7. All people who inject drugs should be screened for _________.

8. Which validated screening tool for predicting prescription opioid misuse is backed by the strongest evidence for its accuracy?

9. In the incarcerated population, which MOUD is effective for treating SUD and improving mental health symptoms?

10. The CDC's recommendations on prescribing opioids do not include _______.

« Return to Activity

Customers who Purchased
this Activity also Purchased